RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma

eLife

Volumn 6, Issue , 2017, Pages

  Arikkatt, Jaisy ^a   Ullah, Md Ashik ^a,b   Short, Kirsty Renfree ^a   Zhang, Vivan ^a   Gan, Wan Jun ^a   Loh, Zhixuan ^a   Werder, Rhiannon B ^a   Simpson, Jennifer ^a   Sly, Peter D ^a   Mazzone, Stuart B ^a   Spann, Kirsten M ^a,c   Ferreira, Manuel A R ^d   Upham, John W ^a   Sukkar, Maria B ^b,e   Phipps, Simon ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; AGER PROTEIN, MOUSE; HMGB1 PROTEIN, MOUSE;

AIRWAY REMODELING; AIRWAY SMOOTH MUSCLE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG TARGETING; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; MOUSE; NONHUMAN; PAUCIGRANULOCYTIC ASTHMA; REINFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; AGRANULOCYTOSIS; ANIMAL; COMPLICATION; DEFICIENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MURINE PNEUMONIA VIRUS; PATHOLOGY; VIRUS LOAD;

AGRANULOCYTOSIS; ANIMALS; ASTHMA; GENETIC PREDISPOSITION TO DISEASE; HMGB1 PROTEIN; MICE; MURINE PNEUMONIA VIRUS; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; VIRAL LOAD;

EID: 85010657845     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.21199     Document Type: Article

References (52)

1. Akirav EM, Henegariu O, Preston-Hurlburt P, Schmidt AM, Clynes R, Herold KC. 2014. The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma. PLoS One 9: e95678. doi: 10.1371/journal.pone.0095678
2. Bonville CA, Bennett NJ, Koehnlein M, Haines DM, Ellis JA, DelVecchio AM, Rosenberg HF, Domachowske JB. 2006. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 349:87-95. doi: 10.1016/j.virol.2006.02.017
3. Davidson S, Kaiko G, Loh Z, Lalwani A, Zhang V, Spann K, Foo SY, Hansbro N, Uematsu S, Akira S, Matthaei KI, Rosenberg HF, Foster PS, Phipps S. 2011. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. The Journal of Immunology 186: 5938-5948. doi: 10.4049/jimmunol.1002635
4. Dyer KD, Schellens IM, Bonville CA, Martin BV, Domachowske JB, Rosenberg HF. 2007. Efficient replication of pneumonia virus of mice (PVM) in a mouse macrophage cell line. Virology Journal 4:48. doi: 10.1186/1743-422X-4-48
5. Ferreira MA, Matheson MC, Tang CS, Granell R, Ang W, Hui J, Kiefer AK, Duffy DL, Baltic S, Danoy P, Bui M, Price L, Sly PD, Eriksson N, Madden PA, Abramson MJ, Holt PG, Heath AC, Hunter M, Musk B, et al. 2014. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. Journal of Allergy and Clinical Immunology 133:1564-1571. doi: 10.1016/j.jaci.2013.10.030
6. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Reports 3:995-1001. doi: 10.1093/embo-reports/kvf19
7. Garvey TL, Dyer KD, Ellis JA, Bonville CA, Foster B, Prussin C, Easton AJ, Domachowske JB, Rosenberg HF. 2005. Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. The Journal of Immunology 175:4735-4744. doi: 10.4049/jimmunol.175.7.4735
8. Hinks TS, Brown T, Lau LC, Rupani H, Barber C, Elliott S, Ward JA, Ono J, Ohta S, Izuhara K, Djukanoví R, Kurukulaaratchy RJ, Chauhan A, Howarth PH. 2016. Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1. Journal of Allergy and Clinical Immunology 138:61-75. doi: 10.1016/j.jaci.2015.11.020
9. Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F. 2011. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Molecular medicine 17:807. doi: 10.2119/molmed.2010.00173
10. Hou XQ, Qin JL, Zheng XX, Wang L, Yang ST, Gao YW, Xia XZ. 2014. Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection. Acta Virologica 58:69-75. doi: 10.4149/av_2014_01_69
11. James KM, Gebretsadik T, Escobar GJ, Wu P, Carroll KN, Li SX, Walsh EM, Mitchel EF, Sloan C, Hartert TV. 2013. Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season. Journal of Allergy and Clinical Immunology 132:227-229. doi: 10.1016/j.jaci.2013.01.009
12. Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH. 2007. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56:199-205. doi: 10.1016/j.metabol.2006.09.01
13. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, Bradding P, Fahy JV, Woodruff PG, Harris JM, Arron JR, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma (BOBCAT) Study Group. 2012. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. Journal of Allergy and Clinical Immunology 130:647-654. doi: 10.1016/j.jaci.2012.06.025
14. Kaiko GE, Loh Z, Spann K, Lynch JP, Lalwani A, Zheng Z, Davidson S, Uematsu S, Akira S, Hayball J, Diener KR, Baines KJ, Simpson JL, Foster PS, Phipps S. 2013. Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. Journal of Allergy and Clinical Immunology 131:1331-1339. doi: 10.1016/j.jaci.2013.02.041
15. Lambrecht BN, Hammad H. 2003. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nature Reviews Immunology 3:994-1003. doi: 10.1038/nri1249
16. Lloyd CM. 2010. IL-33 family members and asthma - bridging innate and adaptive immune responses. Current Opinion in Immunology 22:800-806. doi: 10.1016/j.coi.2010.10.006
17. Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Reviews Immunology 5:331-342. doi: 10.1038/nri1594
18. Lynch JP, Werder RB, Simpson J, Loh Z, Zhang V, Haque A, Spann K, Sly PD, Mazzone SB, Upham JW, Phipps S. 2016. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. Journal of Allergy and Clinical Immunology 138:1326-1337. doi: 10.1016/j.jaci.2016.02.03
19. Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A, Raucci A, Sanvito F, Doglioni C, Nawroth PP, Bierhaus A, Bianchi ME, Rovere-Querini P, Del Maschio A. 2008. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. The Journal of Immunology 180:2270-2275. doi: 10.4049/jimmunol.180.4.2270
20. Maruthur NM, Li M, Halushka MK, Astor BC, Pankow JS, Boerwinkle E, Coresh J, Selvin E, Kao WH. 2015. Genetics of plasma soluble receptor for advanced glycation End-Products and cardiovascular outcomes in a Community-based population: Results from the atherosclerosis risk in communities study. PLoS One 10: e0128452. doi: 10.1371/journal.pone.0128452
21. Moisy D, Avilov SV, Jacob Y, Laoide BM, Ge X, Baudin F, Naffakh N, Jestin JL. 2012. HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication. Journal of Virology 86:9122-9133. doi: 10.1128/JVI.00789-12
22. Nakajima H, Nakao A, Watanabe Y, Yoshida S, Iwamoto I. 1994. IFN-alpha inhibits antigen-induced eosinophil and CD4+ T cell recruitment into tissue. Journal of Immunology 153:1264-1270.
23. Nosaka N, Yashiro M, Yamada M, Fujii Y, Tsukahara H, Liu K, Nishibori M, Matsukawa A, Morishima T. 2015. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice. Critical Care 19:249. doi: 10.1186/s13054-015-0983-9
24. O’Reilly R, Ullmann N, Irving S, Bossley CJ, Sonnappa S, Zhu J, Oates T, Banya W, Jeffery PK, Bush A, Saglani S. 2013. Increased airway smooth muscle in preschool wheezers who have asthma at school age. Journal of Allergy and Clinical Immunology 131:1024-1032. doi: 10.1016/j.jaci.2012.08.044
25. Oczypok EA, Milutinovic PS, Alcorn JF, Khare A, Crum LT, Manni ML, Epperly MW, Pawluk AM, Ray A, Oury TD. 2015. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. Journal of Allergy and Clinical Immunology 136:747-756. doi: 10.1016/j.jaci.2015.03.011
26. Oliphant CJ, Hwang YY, Walker JA, Salimi M, Wong SH, Brewer JM, Englezakis A, Barlow JL, Hams E, Scanlon ST, Ogg GS, Fallon PG, McKenzie AN. 2014. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41:283-295. doi: 10.1016/j.immuni.2014.06.016
27. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, Ballantyne CM, Gahmberg CG, Bianchi ME, Nawroth PP, Chavakis T. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. The EMBO Journal 26:1129-1139. doi: 10.1038/sj.emboj.7601552
28. Pawankar R. 2014. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organization Journal 7:12. doi: 10.1186/1939-4551-7-12
29. Porsbjerg C, Lund TK, Pedersen L, Backer V. 2009. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. Journal of Asthma 46:606-612. doi: 10.1080/02770900903015654
30. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A, Bianchi ME. 2006. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. The FASEB Journal 20:2565-2566. doi: 10.1096/fj.06-5867fje
31. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME. 2008. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). The FASEB Journal 22:3716-3727. doi: 10.1096/fj.08-109033
32. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, Huffman JE, Igl W, Albrecht E, Deloukas P, Henderson J, Granell R, McArdle WL, Rudnicka AR, Barroso I, Loos RJ, et al. 2010. Genome-wide association study identifies five loci associated with lung function. Nature Genetics 42:36-44. doi: 10.1038/ng.501
33. Roponen M, Yerkovich ST, Hollams E, Sly PD, Holt PG, Upham JW. 2010. Toll-like receptor 7 function is reduced in adolescents with asthma. European Respiratory Journal 35:64-71. doi: 10.1183/09031936.00172008
34. Schleich FN, Manise M, Sele J, Henket M, Seidel L, Louis R. 2013. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulmonary Medicine 13:11. doi: 10.1186/1471-2466-13-11
35. Schmidt AM. 2015. Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease. Vascular pharmacology 72:1-8. doi: 10.1016/j.vph.2015.06.011
36. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. 2007. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62:211-218. doi: 10.1136/thx.2006.061358
37. Simpson JL, Scott R, Boyle MJ, Gibson PG. 2006. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11:54-61. doi: 10.1111/j.1440-1843.2006.00784.x
38. Sukkar MB, Ullah MA, Gan WJ, Wark PAB, Chung KF, Hughes JM, Armour CL, Phipps S. 2012. RAGE: a new frontier in chronic airways disease. British Journal of Pharmacology 167:1161-1176. doi: 10.1111/j.1476-5381.012.01984.x
39. Tailor P, Tamura T, Ozato K. 2006. IRF family proteins and type I interferon induction in dendritic cells. Cell Research 16:134-140. doi: 10.1038/sj.cr.7310018
40. Taussig LM, Wright AL, Morgan WJ, Harrison HR, Ray CG. 1989. The tucson children’s respiratory study. I. design and implementation of a prospective study of acute and chronic respiratory illness in children. American Journal of Epidemiology 129:1219-1231
41. Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, Yamamoto Y, Schmidt AM, Armour CL, Hughes JM, Phipps S, Sukkar MB. 2014. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. Journal of Allergy and Clinical Immunology 134: 440-450. doi: 10.1016/j.jaci.2013.12.1035
42. Ulloa L, Messmer D. 2006. High-mobility group box 1 (HMGB1) protein: Friend and foe. Cytokine & Growth Factor Reviews 17:189-201. doi: 10.1016/j.cytogfr.2006.01.003
43. Wang F, He XY, Baines KJ, Gunawardhana LP, Simpson JL, Li F, Gibson PG. 2011. Different inflammatory phenotypes in adults and children with acute asthma. The European Respiratory Journal 38:567-574. doi: 10.1183/09031936.00170110
44. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251. doi: 10.1126/science.285.5425.248
45. Wang H, Yang H, Tracey KJ. 2004. Extracellular role of HMGB1 in inflammation and sepsis. Journal of Internal Medicine 255:320-331. doi: 10.1111/j.1365-2796.2003.01302.x
46. Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K. 2011. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respiratory Medicine 105:519-525. doi: 10.1016/j.rmed.2010.10.016
47. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. 1989. The Tucson children’s Respiratory Study. II. Lower respiratory tract illness in the first year of life. American Journal of Epidemiology 129:1232-1246
48. Xu J, Jiang Y, Wang J, Shi X, Liu Q, Liu Z, Li Y, Scott MJ, Xiao G, Li S, Fan L, Billiar TR, Wilson MA, Fan J. 2014. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death and Differentiation 21: 1229-1239. doi: 10.1038/cdd.2014.40
49. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, Tracey KJ. 2010. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. PNAS 107:11942-11947. doi: 10.1073/pnas.1003893107
50. Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ. 2012. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Molecular Medicine 18:250-259. doi: 10.2119/molmed.2011.00389
51. You D, Saravia J, Siefker D, Shrestha B, Cormier SA. 2015. Crawling with Virus: Translational Insights from a Neonatal Mouse Model on the Pathogenesis of Respiratory Syncytial Virus in Infants. Journal of Virology 90:2-4. doi: 10.1128/JVI.01026-15
52. Zhu L, Ren L, Chen Y, Fang J, Ge Z, Li X. 2015. Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma. Journal of cellular and molecular medicine 19:2128-2135. doi: 10.1111/jcmm.12577